British American Tobacco/£BATS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About British American Tobacco
The second-largest tobacco company by volume, British American Tobacco sold 505 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.
- Ticker
- £BATS
- Sector
- Consumer Essentials
- Primary listing
- LSE
- Employees
- 47,797
- Headquarters
- London, United Kingdom
- Website
- www.bat.com
BATS Metrics
BasicAdvanced
£90B
14.35
£2.91
0.11
£2.43
5.88%
Price and volume
Market cap
£90B
Beta
0.11
52-week high
£53.26
52-week low
£36.77
Average daily volume
3.8M
Dividend rate
£2.43
Financial strength
Current ratio
0.835
Quick ratio
0.479
Long term debt to equity
0.639
Total debt to equity
0.722
Dividend payout ratio (TTM)
82.63%
Interest coverage (TTM)
5.20%
Profitability
EBITDA (TTM)
11,199
Gross margin (TTM)
82.72%
Net profit margin (TTM)
24.99%
Operating margin (TTM)
34.73%
Effective tax rate (TTM)
22.90%
Revenue per employee (TTM)
£540,000
Management effectiveness
Return on assets (TTM)
5.12%
Return on equity (TTM)
13.42%
Valuation
Price to earnings (TTM)
14.348
Price to revenue (TTM)
3.515
Price to book
1.94
Price to tangible book (TTM)
-2.22
Price to free cash flow (TTM)
13.455
Free cash flow yield (TTM)
7.43%
Free cash flow per share (TTM)
3.099
Dividend yield (TTM)
5.82%
Forward dividend yield
5.88%
Growth
Revenue change (TTM)
0.70%
Earnings per share change (TTM)
111.11%
3-year revenue growth (CAGR)
-2.98%
10-year revenue growth (CAGR)
6.78%
3-year earnings per share growth (CAGR)
-9.15%
10-year earnings per share growth (CAGR)
2.30%
3-year dividend per share growth (CAGR)
1.06%
10-year dividend per share growth (CAGR)
4.63%
What the Analysts think about BATS
Analyst ratings (Buy, Hold, Sell) for British American Tobacco stock.
Analyst projections of the future price of British American Tobacco stock.
Bulls say / Bears say
BAT’s New Categories revenue rose 18% at constant currency in the first half, led by Modern Oral growth of 65.9%. Management expects mid-teens growth for these products in 2026, giving the business a growing counterweight to cigarette declines. (British American Tobacco)
In the US, Vuse revenue grew 19.8% and its value share rose 4.1 percentage points to 55.9% in the first half. Planned Vuse flavour launches and a national Velo Max rollout could build on that momentum. (British American Tobacco)
Adjusted diluted EPS rose 7.9% in the first half, while free cash flow before dividends increased 85% to £2.285bn. Strong cash generation supports the £1.3bn 2026 buy-back and the company’s commitment to dividend growth. (British American Tobacco)
BAT expects global cigarette industry volumes to fall about 3% in 2026 and kept its revenue and operating-profit growth outlook at the lower end of its ranges. Continued pressure on its traditional tobacco business leaves less room for setbacks elsewhere. (Reuters)
APMEA revenue fell 6.3% and adjusted operating profit fell 16.5% in the first half, as regulatory changes, illicit trade and competition weighed on the region. A slower-than-expected recovery in Asia remains a drag on performance. (British American Tobacco, Reuters)
A US appeals court allowed a class action to proceed over claims that Natural American Spirit labels misled consumers about cigarette safety and additives. The case adds legal and reputational uncertainty for BAT’s US business. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2026.
BATS Financial Performance
Revenues and expenses
BATS Earnings Performance
Company profitability
Upcoming events
Funds containing BATS
AllEURGBPUSD
Fund name | Fund size | £BATS weighting |
|---|---|---|
iShares STOXX Europe 600 Personal & Household Goods€EXH7 | €184M | 13.78% |
iShares UK Dividend£IUKD | £1.3B | 5.09% |
iShares Core FTSE 100€ISFA | €19B | 3.31% |
iShares Core FTSE 100£CUKX | £3.2B | 3.31% |
iShares Core FTSE 100£ISF | £16B | 3.31% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.